14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
CYD vs SNDA: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 16, 2026, China Yuchai International Ltd. (CYD) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CYD carries a Unified Composite Score of 64.8/100 (BUY) at $21.33 (5.7x Forward P/E, 5.4% operating margin), whereas SNDA carries 44.1/100 (HOLD) at $32.90 (57.1x Forward P/E, -3.1% operating margin).
Growth vs. Quality Trade-Off: CYD earns the overall head-to-head edge with a stronger Unified Composite Score (64.8/100 BUY vs. SNDA 44.1/100 HOLD) and 1.79β · 49% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
Technical & Structure Timing Caution: CYD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile SNDA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CYD vs SNDA. Trailing 12-month operating profitability (CYD 5.4% vs SNDA -3.1%) and valuation multiples (CYD 5.7x vs SNDA 57.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Medical Care Facilities value chain with $1.6B market capitalization and -3.1% operating margin.
OpEx & R&D Reinvestment32.5% of Rev ($193M)
90D Engineering Disclosures0 Published
Investor FAQ CYD vs SNDA Key Questions & Quantitative Answers
As of Nov 16, 2026, China Yuchai International Ltd. (CYD) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). CYD carries a Unified Composite Score of 64.8/100 (BUY) at $21.33 (5.7x Forward P/E, 5.4% operating margin), whereas SNDA carries 44.1/100 (HOLD) at $32.90 (57.1x Forward P/E, -3.1% operating margin). Growth vs. Quality Trade-Off: CYD earns the overall head-to-head edge with a stronger Unified Composite Score (64.8/100 BUY vs. SNDA 44.1/100 HOLD) and 1.79β · 49% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: CYD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 34.0); meanwhile SNDA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 40.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
SNDA leads the Growth & Scale pillar: CYD posts +6.2% YoY revenue growth and +51.9% YoY earnings growth on $3.75B TTM revenue (17.9% gross margin, 5.4% operating margin), compared with SNDA at +131.2% YoY revenue growth and -21.7% YoY earnings growth on $594M TTM revenue (29.4% gross margin, -3.1% operating margin). On trailing 12-month operating scale, CYD generates $3.75B in USD-normalized revenue versus $594M for SNDA. In operating R&D and SG&A reinvestment, CYD deploys 12.5% of Rev ($469M) (0 90-day corporate R&D disclosures) versus 32.5% of Rev ($193M) (0 disclosures) for SNDA.
CYD screens cheaper on headline valuation multiples. CYD trades at 5.7x Forward P/E, 7.8x Trailing P/E, 0.37x PEG, and 0.2x EV/Revenue (7.9% EBITDA margin), whereas SNDA trades at 57.1x Forward P/E, 57.1x Trailing P/E, 2.04x PEG, and 2.7x EV/Revenue (17.3% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CYD (6.4% ROE) versus SNDA (-27.0% ROE) capital efficiency.
In options market volatility and institutional positioning, CYD carries 87.0% implied volatility (10th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.79β · 49% Vol realized risk). By comparison, SNDA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 49% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.